Neuroborreliosis in the South West of England

Epidemiology and Infection

Volumn 136, Issue 12, 2008, Pages 1707-1711

  Lovett, Joanna K ^a   Evans, P H ^b   O'Connell, S ^a   Gutowski, N J ^c  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

^c ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BACTERIUM ANTIBODY; CEFOTAXIME; CEFTRIAXONE; DOXYCYCLINE;

ABDUCENS NERVE PARALYSIS; ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; BORRELIA BURGDORFERI; CEREBROSPINAL FLUID EXAMINATION; CHILD; CLINICAL FEATURE; CONFUSION; DROWSINESS; ERYTHEMA CHRONICUM MIGRANS; FACIAL NERVE PARALYSIS; FEMALE; HEADACHE; HUMAN; LYME DISEASE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENINGISM; MENINGOENCEPHALITIS; MYALGIA; PERIPHERAL NEUROPATHY; RADICULOPATHY; SERODIAGNOSIS; THERAPY DELAY; TICK BITE; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; BORRELIA BURGDORFERI; CHILD; CHILD, PRESCHOOL; ENGLAND; FEMALE; HUMANS; LYME NEUROBORRELIOSIS; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 56349145670     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268808000472     Document Type: Article

References (11)

1. Health Protection Agency. Epidemiology of Lyme borreliosis (http://www.hpa.org.uk/infections/topics_az/zoonoses/lyme_borreliosis/ enhanced.htm). Accessed 14 November 2007.
2. Bateman DE, et al. The neurological complications of Borrelia burgdorferi in the New Forest area of Hampshire. Journal of Neurolology Neurosurgery and Psychiatry 1988; 51: 699-703.
3. Hansen K, Lebech AM. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi speci.c intrathecal antibody production. Brain 1992; 115: 399-423.
4. Kalish RA, et al. Evaluation of study patients with Lyme disease, 10-20-year follow-up. Journal of Infectious Diseases 2001; 183: 453-460.
5. Berglund J, et al. An epidemiologic study of Lyme disease in southern Sweden. New England Journal of Medicine 1995; 333: 1319-1327.
6. Smith R, O'Connell S, Palmer S. Lyme disease surveillance in England and Wales, 1986-1998. Emerging Infectious Diseases 2000; 6: 404-407.
7. Sigal LH. Misconceptions about Lyme disease: Confusions hiding behind ill-chosen terminology. Annals of Internal Medicine 2002; 136: 413-419.
8. Klempner MS, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. New England Journal of Medicine 2001; 345: 85-92.
9. Pfister HW, Rupprecht TA. Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients. International Journal of Medical Microbiology 2006; 296 (Suppl. 40): 11-16.
10. Wormser GP, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases 2006; 43: 1089-1134.
11. European Union Concerted Action on Lyme Borreliosis (EUCALB). Case de.nitions (http://meduni09.edis.at/eucalb/cms/ index.php?option=com_content&task=view&id=42&Itemid=73). Accessed 7 November 2007.